@newsforce.live: In a phase 1/2 trial of 61 patients with advanced pancreatic cancer, daraxonrasib combined with chemotherapy shrank or eliminated tumours in 60.7% of cases. The tumours became undetectable in about one in 12 patients, and disease progression was halted in 90.2%. Researchers said further trials are needed to assess the treatment’s safety and lasting effects before it could be considered for NHS use. Music: This Is News by Grand_Project Source: https://pixabay.com/music/electronic-this-is-news-396456/ License: Pixabay Content License https://pixabay.com/service/license-summary/ Music excerpt, volume adjusted and fade-out added. Opening sound supplied by NEWSFORCE.

NewsForce
NewsForce
Open In TikTok:
Region: US
Saturday 21 November 2026 17:05:04 GMT
146
1
0
0

Music

Download

Comments

There are no more comments for this video.
To see more videos from user @newsforce.live, please go to the Tikwm homepage.

Other Videos


About